What questions should I ask my oncologist about early stage Leukemia
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Questions to Ask Your Oncologist About Early Stage Leukemia
I'm glad you're thinking about what to ask your care team—this is an important part of getting the best care. Here are key questions organized by topic to help you have a thorough conversation with your oncologist:
About Your Diagnosis & Subtype
1. What specific type of leukemia do I have?
- Early stage leukemia can be different subtypes (AML, CML, ALL, etc.), and each is treated differently. Understanding your specific diagnosis is foundational.
2. What does my subtype mean for my treatment options and prognosis?
- According to the NCCN Guidelines for Patients: Acute Myeloid Leukemia, different subtypes of AML are "grouped and treated based on the presence or absence of certain gene mutations or abnormal chromosomes." Your subtype directly affects your treatment plan.
3. What genetic mutations or chromosomal changes does my leukemia have?
- These biomarkers help determine which treatments will work best for you. Ask your doctor to explain what each one means.
About Testing & Monitoring
4. What tests have I had, and what do the results mean?
- The NCCN Guidelines note that "genetic and biomarker tests are used to learn more about your subtype of AML, to target treatment, and to determine the likely course the cancer will take." Ask your doctor to explain your specific results in plain language.
5. Will I need additional tests before starting treatment?
- Early stage leukemia diagnosis typically involves bone marrow biopsy, blood tests, and sometimes imaging. Ask which tests you still need and why.
6. How often will my blood counts and other markers be monitored during treatment?
- Regular monitoring is essential to track how well treatment is working.
About Treatment Options
7. What are my treatment options, and which do you recommend for my situation?
- According to NCCN Guidelines, "treatment for all types of AML will be in phases. The goal of treatment is to put the cancer in remission." Ask your doctor to explain each option and why they're recommending a specific approach.
8. What is the goal of my treatment—remission, cure, or managing symptoms?
- Understanding what "success" looks like for your specific situation helps you set realistic expectations.
9. Will my treatment involve chemotherapy, targeted therapy, or both?
- Different leukemia subtypes respond to different treatments. For example, some types respond well to targeted therapies that focus on specific mutations.
10. Am I a candidate for a clinical trial?
- Clinical trials may offer newer treatment options. Ask if any are appropriate for your diagnosis.
About Side Effects & Quality of Life
11. What side effects should I expect, and how can we manage them?
- Understanding potential side effects helps you prepare and know when to contact your care team.
12. How will treatment affect my daily life, work, and activities?
- Ask about realistic timelines for recovery and when you might feel better.
13. Will treatment affect my fertility or ability to have children?
- The NCCN Guidelines note that "treatment with targeted therapy and other forms of systemic therapy can affect your fertility." If this is important to you, ask about fertility preservation options before starting treatment.
About Your Care Team
14. Who will be managing my care, and how do I contact them?
- Know who your primary oncologist is and how to reach them with questions or concerns.
15. Should I see a leukemia specialist?
- The NCCN Guidelines recommend that "those with AML should be treated at centers experienced in this type of cancer." Ask if your current center specializes in your leukemia subtype.
16. Will I need a bone marrow transplant, and if so, when would that be considered?
- This is an important question for some early stage leukemias. Ask about the role of transplant in your treatment plan.
About Your Specific Situation
17. What is my risk group, and what does that mean?
- According to NCCN Guidelines, "risk groups are used to make decisions about treatment and to gain information about the likely course your cancer will take." Ask where you fall and what that means for your treatment.
18. Are there any factors about my health (age, other conditions) that will affect my treatment options?
- Your overall health and performance status influence what treatments are appropriate.
19. What should I do to prepare for treatment?
- Ask about nutrition, exercise, managing other health conditions, and any lifestyle changes.
Practical Questions
20. What will my treatment schedule look like?
- How often will I need appointments? How long will each visit take? Can I work during treatment?
21. Will my insurance cover the recommended treatment?
- Ask your care team to help you understand coverage before starting.
22. What resources are available to help me—support groups, counseling, financial assistance?
- Many cancer centers have support services available.
Tips for Your Appointment
✓ Bring someone with you to take notes or help you remember information
✓ Write down your questions ahead of time so you don't forget
✓ Ask for clarification if something doesn't make sense—say "Can you explain that in simpler terms?"
✓ Request written information about your diagnosis and treatment plan
✓ Ask for contact information for your care team so you know how to reach them
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Acute Myeloid Leukemia (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Leukemia patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: